Exploring target specificity of antimicrobial peptides through deep learning embeddings

Author(s):  
Lauren Losin ◽  
Daniel Veltri
2016 ◽  
Vol 36 (1-2) ◽  
pp. 1600011 ◽  
Author(s):  
Petra Schneider ◽  
Alex T. Müller ◽  
Gisela Gabernet ◽  
Alexander L. Button ◽  
Gernot Posselt ◽  
...  

Biochemistry ◽  
2003 ◽  
Vol 42 (47) ◽  
pp. 14023-14035 ◽  
Author(s):  
M. Luisa Mangoni ◽  
Niv Papo ◽  
Giuseppina Mignogna ◽  
David Andreu ◽  
Yechiel Shai ◽  
...  

2021 ◽  
Author(s):  
Qinze Yu ◽  
Zhihang Dong ◽  
Xingyu Fan ◽  
Licheng Zong ◽  
Yu Li

Identifying the targets of an antimicrobial peptide is a fundamental step in studying the innate immuneresponse and combating antibiotic resistance, and more broadly, precision medicine and public health. Therehave been extensive studies on the statistical and computational approaches to identify (i) whether a peptide is anantimicrobial peptide (AMP) or a non-AMP and (ii) which targets are these sequences effective to (Gram-positive,Gram-negative, etc.). Despite the existing deep learning methods on this problem, most of them are unable tohandle the small AMP classes (anti-insect, anti-parasite, etc.). And more importantly, some AMPs can havemultiple targets, which the previous methods fail to consider. In this study, we build a diverse and comprehensivemulti-label protein sequence database by collecting and cleaning amino acids from various AMP databases.To generate efficient representations and features for the small classes dataset, we take advantage of a proteinlanguage model trained on 250 million protein sequences. Based on that, we develop an end-to-end hierarchicalmulti-label deep forest framework, HMD-AMP, to annotate AMP comprehensively. After identifying an AMP, itfurther predicts what targets the AMP can effectively kill from eleven available classes. Extensive experimentssuggest that our framework outperforms state-of-the-art models in both the binary classification task and themulti-label classification task, especially on the minor classes. Compared with the previous deep learning methods,our method improves the performance on macro-AUROC by 11%. The model is robust against reduced featuresand small perturbations and produces promising results. We believe HMD-AMP contribute to both the future wet-lab investigations of the innate structural properties of different antimicrobial peptides and build promising empirical underpinnings for precise medicine with antibiotics.


2020 ◽  
Vol 20 ◽  
pp. 882-894 ◽  
Author(s):  
Jielu Yan ◽  
Pratiti Bhadra ◽  
Ang Li ◽  
Pooja Sethiya ◽  
Longguang Qin ◽  
...  

2020 ◽  
Author(s):  
Chenkai Li ◽  
Darcy Sutherland ◽  
S. Austin Hammond ◽  
Chen Yang ◽  
Figali Taho ◽  
...  

Abstract Antibiotic resistance is a growing global health concern prompting researchers to seek alternatives to conventional antibiotics. Antimicrobial peptides (AMPs) are emerging therapeutic agents with promising utility in this domain and using in silico methods to discover novel AMPs is a strategy that is gaining interest. Such methods can filter through large volumes of candidate sequences and reduce lab screening costs. Here we introduce AMPlify, an attentive deep learning model for AMP prediction, and demonstrate its utility in prioritizing peptide sequences derived from the Rana [Lithobates] catesbeiana (bullfrog) genome. We tested the bioactivity of our predicted peptides against a panel of bacterial species, including representatives from the World Health Organization’s “priority pathogens” list. Four of our novel AMPs were active against multiple species of bacteria, including a multi-drug resistant isolate of carbapenemase-producing Escherichia coli, demonstrating the utility of tools like AMPlify in our fight against antibiotic resistance.


2020 ◽  
Author(s):  
Tzu-Tang Lin ◽  
Li-Yen Yang ◽  
I-Hsuan Lu ◽  
Wen-Chih Cheng ◽  
Zhe-Ren Hsu ◽  
...  

AbstractMotivationAntimicrobial peptides (AMPs) are innate immune components that have aroused a great deal of interest among drug developers recently, as they may become a substitution for antibiotics. However, AMPs discovery through traditional wet-lab research is expensive and inefficient. Thus, we developed AI4AMP, a user-friendly web-server that provides an accurate prediction of the antimicrobial activity of a given protein sequence, to accelerate the process of AMP discovery.ResultsOur results show that our prediction model is superior to the existing AMP predictors.AvailabilityAI4AMP is freely accessible at http://symbiosis.iis.sinica.edu.tw/PC_6/[email protected]


Author(s):  
Chenkai Li ◽  
Darcy Sutherland ◽  
S. Austin Hammond ◽  
Chen Yang ◽  
Figali Taho ◽  
...  

AbstractAntibiotic resistance is a growing global health concern prompting researchers to seek alternatives to conventional antibiotics. Antimicrobial peptides (AMPs) are emerging therapeutic agents with promising utility in this domain and using in silico methods to discover novel AMPs is a strategy that is gaining interest. Such methods can filter through large volumes of candidate sequences and reduce lab screening costs. Here we introduce AMPlify, an attentive deep learning model for AMP prediction, and demonstrate its utility in prioritizing peptide sequences derived from the Rana [Lithobates] catesbeiana (bullfrog) genome. We tested the bioactivity of our predicted peptides against a panel of bacterial species, including representatives from the World Health Organization’s “priority pathogens” list. Four of our novel AMPs were active against multiple species of bacteria, including a multi-drug resistant isolate of carbapenemase-producing Escherichia coli, demonstrating the utility of tools like AMPlify in our fight against antibiotic resistance.


mSystems ◽  
2021 ◽  
Author(s):  
Tzu-Tang Lin ◽  
Li-Yen Yang ◽  
I-Hsuan Lu ◽  
Wen-Chih Cheng ◽  
Zhe-Ren Hsu ◽  
...  

Antimicrobial peptides (AMPs) are innate immune components that have aroused a great deal of interest among drug developers recently, as they may become a substitute for antibiotics. New candidates need to fight antibiotic resistance, while discovering novel AMPs through wet-lab screening approaches is inefficient and expensive.


Sign in / Sign up

Export Citation Format

Share Document